PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,073,884 | -1.9% | 989,232 | 0.0% | 13.66% | +29.3% |
| Q2 2023 | $6,192,592 | +31.2% | 989,232 | 0.0% | 10.56% | +12.1% |
| Q1 2023 | $4,718,637 | -45.2% | 989,232 | 0.0% | 9.42% | -33.0% |
| Q4 2022 | $8,606,318 | -26.9% | 989,232 | 0.0% | 14.05% | -23.4% |
| Q3 2022 | $11,772,000 | -16.5% | 989,232 | 0.0% | 18.33% | -5.5% |
| Q2 2022 | $14,097,000 | -31.6% | 989,232 | 0.0% | 19.40% | +23.7% |
| Q1 2022 | $20,596,000 | -9.9% | 989,232 | 0.0% | 15.68% | +52.3% |
| Q4 2021 | $22,851,000 | – | 989,232 | – | 10.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,869,911 | $115,323,000 | 47.76% |
| Euclidean Capital LLC | 2,769,813 | $82,540,000 | 40.12% |
| Logos Global Management LP | 1,400,000 | $41,720,000 | 3.01% |
| Orbimed Advisors | 7,330,423 | $218,447,000 | 2.40% |
| Boxer Capital, LLC | 2,268,236 | $67,593,000 | 2.36% |
| PERSONAL CFO SOLUTIONS, LLC | 355,342 | $10,589,000 | 2.17% |
| Asymmetry Capital Management, L.P. | 100,882 | $3,006,000 | 1.81% |
| Avoro Capital Advisors LLC | 2,925,000 | $87,165,000 | 1.37% |
| COMMODORE CAPITAL LP | 125,000 | $3,725,000 | 0.98% |
| HighVista Strategies LLC | 39,777 | $1,185,000 | 0.78% |